Antipsychotic drugs remain the standard for schizophrenia treatment. Despite their effectiveness in treating hallucinations and delusions, prolonged exposure to antipsychotic medications leads to cognitive deficits in both schizophrenia patients and animal models. The molecular mechanisms underlying these negative effects on cognition remain to be elucidated. Here we demonstrate that chronic antipsychotic drug exposure increases nuclear translocation of NF-κB in both mouse and human frontal cortex, a trafficking event triggered via 5-HT2A-receptor-dependent downregulation of the NF-κB repressor IκBα. This upregulation of NF-κB activity led to its increased binding at the Hdac2 promoter, thereby augmenting Hdac2 transcription. Deletion of HDAC2 in forebrain pyramidal neurons prevented the negative effects of antipsychotic treatment on synaptic remodeling and cognition. Conversely, virally mediated activation of NF-κB signaling decreased cortical synaptic plasticity via HDAC2. Together, these observations may aid in developing therapeutic strategies to improve the outcome of schizophrenia treatment.
G protein-coupled receptors (GPCRs) are a remarkably multifaceted family of transmembrane proteins that exert a variety of physiological effects. Although family A GPCRs are able to operate as monomers, there is increasing evidence that heteromerization represents a fundamental aspect of receptor function, trafficking and pharmacology. Most recently, it has been suggested that GPCR heteromers may play a crucial role as new molecular targets of heteromer-selective and bivalent ligands. The current review summarizes key recent developments in these topics.
Several pharmacophore models have been proposed for 5-HT2A serotonin receptor antagonists. These typically consist of two aromatic/hydrophobic moieties separated by a given distance from each other, and from a basic amine. Although specified distances might vary, the models are relatively similar in their general construction. Because our preliminary data indicated that two aromatic (hydrophobic) moieties might not be required for such action, we deconstructed the serotonin-dopamine antipsychotic agent risperidone (1) into four smaller structural fragments that were thoroughly examined in 5-HT2A receptor binding and functional (i.e., two-electrode voltage clamp – TEVC – and intracellular calcium release) assays. It was apparent that truncated risperidone analogs behaved as antagonists. In particular, 6-fluoro-3-(1-methylpiperidin-4-yl)benzisoxazole (4) displayed high affinity for 5-HT2A receptors (Ki
ca 12 nM) relative to risperidone (Ki
ca 5 nM) and behaved as a potent 5-HT2A serotonin receptor antagonist. These results suggest that multiple aromatic (hydrophobic) moieties are not essential for high-affinity 5-HT2A receptor binding and antagonist activity and that current pharmacophore models for such agents are very much in need of revision.
Highlights d Photoactivatable unnatural amino acids inform the structural interface of 5-HT 2A R-mGluR2 d TAG mGluR2 constructs were co-expressed with 5-HT 2A R for photo-crosslinking d UV-induced crosslinking only in cells co-expressing 5-HT 2A R and mGluR2-TAG 4.44 d 5-HT 2A R interacts with mGluR2 via the intracellular end of mGluR2's TM4
Pharmacophore
models for 5-HT2A receptor antagonists
consist of two aromatic/hydrophobic regions at a given distance from
a basic amine. We have previously shown that both aromatic/hydrophobic
moieties are unnecessary for binding or antagonist action. Here, we
deconstructed the 5-HT2A receptor antagonist/serotonin-dopamine
antipsychotic agent risperidone into smaller structural segments that
were tested for 5-HT2A receptor affinity and function.
We show, again, that the entire risperidone structure is unnecessary
for retention of affinity or antagonist action. Replacement of the
6-fluoro-3-(4-piperidinyl)-1,2-benz[d]isoxazole moiety
by isosteric tryptamines resulted in retention of affinity and antagonist
action. Additionally, 3-(4-piperidinyl)-1,2-benz[d]isoxazole (10), which represents less than half the
structural features of risperidone, retains both affinity and antagonist
actions. 5-HT2A receptor homology modeling/docking studies
suggest that 10 binds in a manner similar to risperidone
and that there is a large cavity to accept various N4-substituted
analogues of 10 such as risperidone and related agents.
Alterations of this “extended” moiety improve receptor
binding and functional potency. We propose a new risperidone-based
pharmacophore for 5-HT2A receptor antagonist action.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.